SL-75102

SL-75102
Names
	IUPAC name 4-[[(4-Chlorophenyl)-(3-fluoro-6-oxocyclohexa-2,4-dien-1-ylidene)methyl]amino]butanoic acid
	Other names Progabide acid; LS-187121; SL-75-102-00
Identifiers
CAS Number	62665-97-8 ;
3D model (JSmol)	Interactive image;
ChEBI	CHEBI:368340;
ChEMBL	ChEMBL160058;
ChemSpider	20121433;
PubChem CID	6140507;
UNII	74JC6VM0KD ;
	InChI InChI=1S/C17H15ClFNO3/c18-12-5-3-11(4-6-12)17(20-9-1-2-16(22)23)14-10-13(19)7-8-15(14)21/h3-8,10,21H,1-2,9H2,(H,22,23)/b20-17+ Key: RRAXPPHKWFOGGL-LVZFUZTISA-N;
	SMILES c1cc(ccc1/C(=N\CCCC(=O)O)/c2cc(ccc2O)F)Cl;
Properties
Chemical formula	C17H15ClFNO3
Molar mass	335.76 g·mol−1
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references

Progabide acid, also known as SL-75.102, is a GABA receptor agonist and an active metabolite of the anticonvulsant drug progabide.^[1]^[2]^[3]

References

↑ Bergmann KJ (1985). "Progabide: a new GABA-mimetic agent in clinical use". Clin Neuropharmacol. 8 (1): 13–26. doi:10.1097/00002826-198503000-00002. PMID 2983890.
↑ Hamberger, C.; Barre, J.; Brandebourger, M.; Urien, S.; Taiclet, A.; Thenot, J. P.; Tillement, J. P. (April 1987). "Progabide and SL 75102 binding to plasma proteins and red blood cells in humans". Int J Clin Pharmacol Ther Toxicol. 25 (4): 178–184. PMID 3583466.
↑ Kubová, H.; Haugvicová, R.; Mares, P. (1997). "Anticonvulsant effect of SL 75 102 in adult and immature rats". Physiol Res. 46 (1): 73–76. PMID 9728525.

This anticonvulsant-related article is a stub. You can help Wikipedia by adding missing information.